Abstract

In this research, direct batch and flow injection (FI) spectrophotometric methods for the analysis of piroxicam (PIX) in commercial dosage forms were investigated. The methods were based on the reaction of PIX with diazotized metoclopramide in alkaline medium to form orange color product at room temperature which absorbs maximally at λmax 472 nm. Chemical and physical variables of batch and FI methods were optimized to produce high sensitivity and reproducibility. Under the optimized experimental conditions, Beer’s law was obeyed over concentration ranges from 1 - 35 and 10 - 250 μg/mL PIX with limits of detection of 0.2 and 3.4 μg/mL and limits of quantification of 0.7 and 11.4 μg/mL PIX for batch and FI procedures, respectively. The relative standard deviation (%RSD) was less than 0.7 and 2.4 for batch and FI procedures respectively with a sample throughput of 38 h-1 for FI procedure. The proposed methods can be used for the routine analysis for the assay of PIX in injections and capsules.
 
 Bull. Chem. Soc. Ethiop. 2020, 34(1), 13-23.
 DOI: https://dx.doi.org/10.4314/bcse.v34i1.2

Highlights

  • Piroxicam (PIX) (C15H13N3O4S) is chemically known as 4-hydroxy-2-methyl-3-(N-pyridil-2)carboxyamido-2H,2-benzothiazine-1,1-dioxide

  • Diazotized metoclopramide has been used as an efficient coupling reagent in several spectrophotometric reactions [27, 28]

  • All the parameters that enhance the sensitivity of the diazotization reaction and the assay of PIX drug were studied

Read more

Summary

Introduction

Piroxicam (PIX) (C15H13N3O4S) is chemically known as 4-hydroxy-2-methyl-3-(N-pyridil-2)carboxyamido-2H-,2-benzothiazine-1,1-dioxide. The present work describes the development of direct batch and FIA methods for the determination of PIX using another drug (metoclopramide (MP)) as a green and safe reagent.

Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.